John Nasseff Neuroscience Institute

Minneapolis, Minnesota 55407

0 studies enrolling now · 3 studies all time

What they study most

Glioblastoma, Glioblastoma Multiforme, Glioma, Gliosarcoma, Malignant Brain Tumor

Studies at this site

• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed
• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma — Paused
• Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors — Completed